Magazine Article | July 1, 2021

How A First-Time CEO Transformed Retrophin Into Travere Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

“ARE YOU KIDDING ME?”

That was the first thought Eric Dube, Ph.D., had when an executive recruiter pitched to him a CEO opportunity at Retrophin back in 2018. After all, Dube knew of the San Diego-based biopharma’s infamous past with its cofounder and one-time CEO, Martin Shkreli, so his initial reaction was to be dubious.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: